Clinical Research Directory
Browse clinical research sites, groups, and studies.
Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism
Sponsor: University of Alabama at Birmingham
Summary
Options for treatment of severe, refractory hypocalcemia are limited for the thousands of patients in the United States who suffer from hypoparathyroidism. Parathyroid allotransplantation is an emerging treatment that provides hope for these individuals. Currently, this therapy has only been successfully provided by a few centers in the world. In the UAB PATH trial, we propose to become one of the few centers worldwide to successfully achieve parathyroid allotransplantation in transplant-naïve patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2027-07
Completion Date
2030-01
Last Updated
2025-07-11
Healthy Volunteers
No
Conditions
Interventions
Parathyroid Allotransplant
Patients that meet inclusion criteria and are enrolled in the trial will undergo parathyroid allotransplantation
Locations (1)
University of Alabama at Birmingham
Birmingham, Alabama, United States